These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 16179524)
1. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Chuang DM Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524 [TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Shao L; Young LT; Wang JF Biol Psychiatry; 2005 Dec; 58(11):879-84. PubMed ID: 16005436 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Chuang DM Crit Rev Neurobiol; 2004; 16(1-2):83-90. PubMed ID: 15581403 [TBL] [Abstract][Full Text] [Related]
6. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH; McNamara RK; Watterson JM; Watson DG J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [TBL] [Abstract][Full Text] [Related]
7. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795 [TBL] [Abstract][Full Text] [Related]
8. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death. Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485 [TBL] [Abstract][Full Text] [Related]
9. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090 [TBL] [Abstract][Full Text] [Related]
10. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Umeda K; Suemaru K; Todo N; Egashira N; Mishima K; Iwasaki K; Fujiwara M; Araki H Eur J Pharmacol; 2006 Dec; 553(1-3):157-62. PubMed ID: 17070517 [TBL] [Abstract][Full Text] [Related]
11. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. Manji HK; Moore GJ; Chen G J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666 [TBL] [Abstract][Full Text] [Related]
12. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons. Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798 [TBL] [Abstract][Full Text] [Related]
13. Valproate and neuroprotective effects for bipolar disorder. Atmaca M Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154 [TBL] [Abstract][Full Text] [Related]
14. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. Hashimoto R; Hough C; Nakazawa T; Yamamoto T; Chuang DM J Neurochem; 2002 Feb; 80(4):589-97. PubMed ID: 11841566 [TBL] [Abstract][Full Text] [Related]
15. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Cui J; Shao L; Young LT; Wang JF Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924 [TBL] [Abstract][Full Text] [Related]
16. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers. Watson DG; Watterson JM; Lenox RH J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026 [TBL] [Abstract][Full Text] [Related]
17. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. Ren M; Leng Y; Jeong M; Leeds PR; Chuang DM J Neurochem; 2004 Jun; 89(6):1358-67. PubMed ID: 15189338 [TBL] [Abstract][Full Text] [Related]
18. Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades. Laing JM; Golembewski EK; Wales SQ; Liu J; Jafri MS; Yarowsky PJ; Aurelian L J Neurosci Res; 2008 Feb; 86(2):378-91. PubMed ID: 17893911 [TBL] [Abstract][Full Text] [Related]
19. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367 [TBL] [Abstract][Full Text] [Related]
20. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Plant KE; Anderson E; Simecek N; Brown R; Forster S; Spinks J; Toms N; Gibson GG; Lyon J; Plant N Toxicol Appl Pharmacol; 2009 Feb; 235(1):124-34. PubMed ID: 19101580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]